Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse
Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse
Recruiting · NCT06271057 · Registry updated 2026-06-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse | Diffuse Large B-cell Lymphoma Refractory; Refractory High Grade B-Cell Lymphoma; Refractory Primary Mediastinal Large B-Cell Lymphoma; Refractory Transformed B-cell Non-Hodgkin Lymphoma | Recruiting | Phase 2 | 2026-06-04 | NCT06271057 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Lymphoma Study Association | 5 |
| The Lymphoma Academic Research Organisation | 20 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Henri Becquerel | Rouen | France | 59 |
| CHRU de Lille | Lille | France | 13 |
| CHU Brabois | Vandœuvre-lès-Nancy | France | 5 |
| CHU de Bordeaux | Pessac | France | 8 |
| CHU de Grenoble | La Tronche | France | 7 |
| CHU de Montpellier | Montpellier | France | 13 |
| Chu de Nantes | Nantes | France | 72 |
| Chu Dijon Bourgogne | Dijon | France | 69 |
| CHU Pontchaillou | Rennes | France | 8 |
| Hopital Henri Mondor | Créteil | France | 23 |
| Hopital Saint-Louis | Paris | France | 3 |
| Institut Paoli Calmettes | Marseille | France | 38 |
| IUCT Oncopole | Toulouse | France | 12 |